Tudor Investment Corp
VRDN icon

Tudor Investment Corp’s Viridian Therapeutics VRDN Stock Holding History

Tudor Investment Corp’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,597
Closed -$1.61M – 4661
2025
Q4 		$1.61M Buy
+51,597
New +$1.42M 0.01% 1972
2025
Q1 		– Sell
-38,367
Closed -$735K – 4001
2024
Q4 		$735K Buy
38,367
+1,106
+3% +$24K 0.01% 1955
2024
Q3 		$848K Buy
+37,261
New +$609K 0.01% 1725
2024
Q1 		– Sell
-30,218
Closed -$658K – 2997
2023
Q4 		$658K Buy
+30,218
New +$477K 0.01% 1643
2023
Q2 		– Sell
-24,110
Closed -$613K – 3125
2023
Q1 		$613K Buy
+24,110
New +$773K 0.01% 1502

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return